Bristol James Arthur has filed 8 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 37762 shares of Erasca, Inc. ($ERAS) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Erasca, Inc. | $ERAS | Bristol James Arthur | Not found | A | Stock Option (right to buy) | 37762 | $0.00 | 37,762.0000 | 283,711,805 | 9999.99% | 0.01% |
| June 24, 2025 | Erasca, Inc. | $ERAS | Bristol James Arthur | Not found | A | Stock option (right to buy) | 120000 | $0.00 | 120,000.0000 | 283,265,716 | 9999.99% | 0.04% |
| Feb. 7, 2025 | Ernexa Therapeutics Inc. | $ERNA | Bristol James Arthur | Director | A | Stock Option (Right to buy) | 72074 | $0.00 | 72,074.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Erasca, Inc. | $ERAS | Bristol James Arthur | Not found | A | Stock Option (right to buy) | 45678 | $0.00 | 45,678.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Erasca, Inc. | $ERAS | Bristol James Arthur | Director | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 26, 2024 | Ernexa Therapeutics Inc. | $ERNA | Bristol James Arthur | Not found | A | Stock Option (Right to buy) | 124525 | $0.00 | 124,525.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Erasca, Inc. | $ERAS | Bristol James Arthur | Director | A | Stock Option (right to buy) | 62747 | $0.00 | 62,747.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Erasca, Inc. | $ERAS | Bristol James Arthur | Director | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |